Pyxis Oncology, Inc. · NASDAQ:PYXS
BVF PARTNERS L P/IL reported a 9.99% stake in Pyxis Oncology, Inc. (Schedule 13G)
Event Jul 2, 2026 · Filed Jul 10, 2026
BVF PARTNERS L P/IL reported a 9.99% stake in Pyxis Oncology, Inc., 8,336,902 shares, as a passive investor on Jul 2, 2026. Filed Jul 10, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 8,336,902
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.50% | 4,611,887 |
| BVF I GP LLC | 5.50% | 4,611,887 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.70% | 3,083,847 |
| BVF II GP LLC | 3.70% | 3,083,847 |
| Biotechnology Value Trading Fund OS LP | 0.60% | 518,280 |
| BVF Partners OS Ltd. | 0.60% | 518,280 |
| BVF GP HOLDINGS LLC | 9.20% | 7,695,734 |
| BVF PARTNERS L P/IL | 9.99% | 8,336,902 |
| BVF INC/IL | 9.99% | 8,336,902 |
| LAMPERT MARK N | 9.99% | 8,336,902 |
Source
Related
- Pyxis Oncology, Inc.
- Bvf Partners L P
- Pyxis Oncology, Inc. shareholders
- Schedule 13G/A · GordonMD Global Investments LP · Oct 9, 2026
- Schedule 13G · Coastlands Capital LP · Oct 5, 2026
- Form 4 · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G/A · GordonMD Global Investments LP · Oct 2, 2026
- Form 4 · Dupont Jakob · Jul 2, 2026